The Australian Therapeutics Goods Admin. warned patients of 3 issues, but noted that "these issues are rare and it is unlikely that you will need to replace your Medtronic Paradigm Insulin Pump."
Certain models of the insulin pumps may exhibit loose drive support caps, especially if the device hits a hard surface. The support cap holds the device’s motor in place and helps deliver insulin.
Regulators have received word of at least 1 patient who attempted to put the loose cap back in place and accidentally injected a dose of insulin, resulting in severe hypoglycemia, according to the report.
The devices may also exhibit a "sensor graph timeout," which may prevent the insulin pump from automatically resuming its basal delivery.
Finally, the authorities warned that exposure to water may damage the pump’s internal electronics. The Paradigm pumps are "designed to withstand splashing or brief dunking, but should not be immersed in water," according to the advisory.
Medtronic sent warnings to healthcare providers, advising them to make sure patients are informed about the potential issues and how to circumvent them, the TGA said.
Did attachers hack Israel’s Ministry of Health?
Rumors circulated that an anonymous group of "hacktivists" have infiltrated the Israeli Ministry of Health, exposing user names, passwords and email addresses for 3 administrative accounts.
Medtronic named among Canada’s best workplaces
Canada’s Great Place to Work Institute named medtech giant Medtronic’s (NYSE:MDT) Canadian office among the best large workplaces, based on a survey of employees and a "Culture Audit."
Bad news for St. Jude is good for Boston Scientific, analysts say
Ongoing drama for medtech giant St. Jude Medical (NYSE:STJ) and its Durata defibrillator leads, which have suffered the backlash from the recall of the Riata and Riata ST predecessors, may be good news for rival Boston Scientific (NYSE:BSX) in its efforts to gain share in the cardiac rhythm management market.